View in EDS HTML Full Text PDF Full Text

XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Saved in:
Bibliographic Details
Title: XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Authors: Woelfel, Simon1,2 (AUTHOR), Dütschler, Joel1,3 (AUTHOR), Junker, Daniel4 (AUTHOR), König, Marius1 (AUTHOR), Graf, Nicole5 (AUTHOR), Krieger, Claudia1 (AUTHOR), Truniger, Samuel1,3 (AUTHOR), Oikonomou, Vasileios6 (AUTHOR), Leinenkugel, Georg7 (AUTHOR), Koller, Seraina1 (AUTHOR), Metzger‐Peter, Katline7 (AUTHOR), Wyss, Jacqueline6 (AUTHOR), Krupka, Niklas6 (AUTHOR), Frei, Nicola1 (AUTHOR), Albrich, Werner C.8 (AUTHOR), Friedrich, Matthias9 (AUTHOR), Niess, Jan Hendrik7,10 (AUTHOR), Schneiderhan‐Marra, Nicole4 (AUTHOR), Dulovic, Alex4 (AUTHOR), Misselwitz, Benjamin6,11 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jan2025, Vol. 61 Issue 2, p299-312. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.18349